Describe a set of strategic decisions facing the founder and CEO of a promising early stage biopharmaceutical company.l If the company establish a proposed alliance with a pharmaceutical company scientist? Should there be a nutraceutical company, in addition to its efforts to develop therapies against aging? And if it is a license to develop second candidate drugs?
by
Toby Stuart,
David Kiron
Source: Harvard Business School
24 pages.
Date Posted: March 20, 2008. Prod #: 808112-PDF-ENG
Sirtris Pharmaceuticals: a healthier life, solving the case more
Related Case Solutions:
Sirtris Pharmaceuticals: Living Healthier, Longer
Sirtris Pharmaceuticals: Living Healthier Longer (Abridged)
Sirtris Pharmaceuticals: Living Healthier, Longer (Abridged)
GSKs Acquisition of Sirtris: Independence or Integration (Abridged)
Endo Pharmaceuticals (A): From LBO to …
Living Lean: Bobs A-maize-ing Popcorn
Living Lean: Jackson and Wyatt Learn to Share
Business Plan: Senior Living/Assisted Living Company
The Corporate Implications of Longer Lives
A Framework for Healthier Choices: The Hot-Cold Decision Triangle